Leukemia Clinical Trials

A listing of Leukemia medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1542 clinical trials
None
The Humanized Monoclonal Antibody Milatuzumab for Refractory Chronic Lymphocytic Leukemia (CLL)

The purpose of this study is to determine whether Milatuzumab is effective in patients with refractory chronic lymphocytic leukemia, and also to find out in which range of doses is a

cytopenia
monoclonal antibodies
chronic lymphocytic leukemia refractory
monoclonal protein
lymphadenopathy
  • 20 views
  • 07 Nov, 2020
  • 1 location
None
Efficacy and Safety of Nipent Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

This research study measures the safety and efficacy of the combination of three drugs that are approved, Nipent, Rituxan and Cytoxan in the treatment of Chronic Lymphocytic Leukemia (CLL

rituxan
lymphoid leukemia
  • 389 views
  • 07 Nov, 2020
  • 1 location
None
Study of NRX 195183 Therapy for Patients With Relapsed or Refractory Acute Promyelocytic Leukemia

The purpose of this study is to determine whether NRX 195183 is effective in the treatment of relapsed or refractory Acute Promyelocytic Leukemia

nrx 195183
arsenic
cytotoxic chemotherapy
tretinoin
  • 7 views
  • 07 Nov, 2020
  • 1 location
None
Lentivirus Transduced Acute Myeloid Leukaemia Blasts Expressing B7.1 (CD80) and IL-2

The purpose of this study is to assess the safety and tolerability of an 'AML Cell Vaccine' in patients with poor prognosis acute myeloid leukaemia (AML).

graft versus host disease
remission
  • 17 views
  • 07 Nov, 2020
  • 1 location
None
Cladribine Cytarabine and Idarubicin in Patients With Relapsed Acute Myelocytic Leukemia (AML)

The purpose of this study is to evaluate the safety and the efficacy of cladribine, high-dose cytarabine and idarubicin in the treatment of patients with relapsed acute myeloid leukemia.

idarubicin
cytarabine
cladribine
remission
  • 38 views
  • 07 Nov, 2020
  • 1 location
None
Randomised Prospective Comparison of the NMA Allograft and the Traditional Allograft in Acute Myeloid Leukaemia

acute myeloid leukaemia (AML) of the adult for the patients of less than 55 years, because it offers chances of cure higher than chemotherapy or the auto-graft. However, mortality related to

cyclophosphamide
daunorubicin
total body irradiation
remission
idarubicin
  • 18 views
  • 07 Nov, 2020
  • 1 location
None
Single Agent Arsenic Trioxide in the Treatment of Newly Diagnosed Acute Promyelocytic Leukemia

There is very limited data on the use of arsenic trioxide in newly diagnosed patients with acute promyelocytic leukemia. The use of arsenic trioxide was limited to relapsed patients

hepatic toxicity
arsenic
tretinoin
remission
  • 76 views
  • 07 Nov, 2020
  • 8 locations
None
Applying Pediatric Regimens to Younger Adult Patients With Acute Lymphoblastic Leukemia (ALL)

The purpose of this study is to investigate the efficacy and safety for treating adult ALL patients with the pediatric protocol.

mercaptopurine
dexamethasone
adult acute lymphocytic leukemia
cytarabine
cyclophosphamide
  • 7 views
  • 07 Nov, 2020
  • 1 location
None
Study of Liposomal Annamycin in Patients With Refractory or Relapsed Acute Lymphocytic Leukemia

in patients with refractory or relapsed acute lymphocytic leukemia.

lymphoid leukemia
  • 26 views
  • 07 Nov, 2020
  • 1 location
None
Safety and Efficacy of Curcumin in Children With Acute Lymphoblastic Leukemia

Assessment of of the biological effects of curcumin on microbiota in children with acute lymphoblastic leukemia

  • 0 views
  • 24 Sep, 2021